PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:35 pm Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
PRICE T ROWE ASSOCIATES INC | 3,811,568 7.700% |
1,265,783 (+49.72%) |
Filing |
| 2021-02-16 12:24 pm Purchase |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
PRICE T ROWE ASSOCIATES INC | 2,545,785 5.200% |
2,545,785 (New Position) |
Filing |